Prostate cancer decisions — 2022

The Board has remanded the issues of service connection for various conditions, including renal disease, brain aneurysm, cerebrovascular accident, prostate cancer, diabetes mellitus, and blood clots, all claimed to be due to in-service chemical exposure. The AOJ is directed to verify the Veteran's claimed exposures.

The Board has decided to remand the case due to inadequate opinions regarding whether the Veteran's testicular cancer is secondary to his service-connected prostate cancer. The case will be returned for further development and an adequate opinion.

The Veteran's prostate cancer residuals are now rated at 60 percent effective February 22, 2021. The Veteran's PTSD is rated at 100 percent beginning May 30, 2019.

Service connection is granted for prostate cancer, hypothyroidism, and erectile dysfunction due to herbicide agent exposure.,The Veteran's acquired psychiatric disorder (likely depression) is remanded for further examination.

The Board has remanded the case due to inadequate medical opinions and a need for additional service records. The Veteran's prostate cancer and its residuals are being reviewed again with new evidence and examinations.

The Veteran's claim for service connection for prostate cancer due to Agent Orange exposure is remanded because the AOJ did not consider his account of exposure and relevant operational reports.

The Board has granted service connection for prostate cancer, erectile dysfunction, urinary incontinence, bilateral hearing loss, and tinnitus. Service connection was denied for an acquired psychiatric disorder (anxiety).

The Veteran's claims for increased ratings for bilateral hearing loss and prostate cancer are being remanded due to inadequate examination reports. The Board requires a new VA examination to assess the severity of these conditions, including any renal dysfunction in the case of prostate cancer.

The Veteran's service-connected bilateral upper extremity peripheral neuropathy required regular aid and attendance of another person, leading to the grant of SMC based on this condition. The prostate cancer was separately considered for a higher rate of SMC.

The Board has decided to remand the case due to inadequate discussion of the etiology of the Veteran's prostate cancer and a need for a new VA opinion.

The Veteran's appeals for service connection for prostate cancer, PTSD, hypertension, and stroke residuals have been dismissed due to the death of the Veteran.

The Board has granted service connection for residuals of prostate cancer due to herbicide exposure, but the issues regarding erectile dysfunction and urinary dysfunction are remanded as additional development is needed.

The Veteran's prostate cancer is granted as service connected due to his exposure to chemical agents during military service.

The Veteran's adjustment disorder with anxiety and depressed mood associated with prostate cancer was denied an evaluation in excess of 30 percent from April 14, 2016 to February 13, 2020. The issue of a rating in excess of 50 percent for the same condition from February 14, 2020 is also denied.

The claims for service connection of hypertension, diabetes mellitus, prostate cancer, diabetic retinopathy, and renal insufficiency status post kidney transplant have been granted due to the submission of new evidence. The claims are now pending for further adjudication.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no credible evidence demonstrating actual exposure to herbicide agents during his time at U-Tapao Royal Thai Air Force Base. The Board also noted that the Veteran did not have a diagnosis of prostate cancer until many years after separation from service.

The Veteran's claim for an initial disability rating in excess of 20 percent for diabetes mellitus, type II, and a higher rating for prostate cancer from June 28, 2012, is being remanded due to the need for additional medical opinions.,An effective date earlier than December 5, 2006, for service connection of diabetes mellitus, type II, and an earlier effective date than May 19, 2008, for prostate cancer are denied.

The appeal for service connection of a breast disorder is dismissed. The claim for service connection of bilateral hearing loss has been reopened, but the issue remains remanded due to lack of evidence supporting the claim. Other issues remain remanded.

The Veteran's appeal for service connection for various conditions, including a psychiatric disorder, heart condition, diabetes, hypertension, prostate cancer, glaucoma, and hyperlipidemia, is dismissed as the Veteran withdrew his claim. The evidence does not support any of these claims.

The Board dismissed the appeals regarding increased rating for coronary artery disease, service connection for prostate cancer, and service connection for obstructive sleep apnea due to the appellant's death.